D
DEURALI JANTA PHARMACEUTICALS PVT.
Deurali-Janta, established on 1991, is a market leader pharmaceutical company dedicated in providing better products for the healthcare management of the people. All our efforts are directed towards manufacturing quality products for the treatment of various diseases and ailments of the people. Over the years we are focusing our efforts in integration of technology and developing skilled manpower for producing safe and efficacious drugs at an affordable price resulting in the pioneered formulation of therapeutic products for the people in need. Deurali Janta has stepped up to the challenge proffered by the health sector of Nepal. To tackle the problems of health in Nepal this organization has been developing and distributing quality products at a proportionate price to the citizens of Nepal and aims to expand globally. Indeed the company has received international recognition and has been awarded the prestigious certifications of the WHO GMP, ISO 14001:2000 & ISO 9001:2000 which demonstrates our commitment on quality of our products and services. Our primary research and development efforts are directed towards developing high quality pharmaceutical products for the management of chronic as well as acute disease conditions. We aim to develop new products matching the fast paced development of the 21st century alongside periodic updates to the formulas of all the drugs that we currently produce matching the trends worldwide. Our primary areas of interest are in infections, cardiology, women's health, infectious disease and we see exciting opportunities to develop innovative products for enhancing healthier living - which will help people to live a healthy and productive life. We also develop and produce drugs popularly in demand in the international marked but not available in our internal market, like our drug for stomach ailments, Peptonorm. Our investment in technologies and products will allow us expansion to new therapeutic segments required for the healthier living of the people. Our focus is to become ...
Country/Area ：Nepal
Company Email ：admin@deuralijanta.com
Industry ：Manufacturing GeneralManufacturing
Company address ：Kathmandu, Central Region, Nepal
Company website ：*****
Company phone ：+977 14353935
Established ：-
Company Revenue ：$6,442,000
Number of employees ：<25
SIC Code ：28283
NAICS Code ：32325
Main Products ：RESEARCH & DEVELOPMENTSales Force AutomationREGULATORY MANAGEMENTSOCIAL WELFARETIPS & FACTSGLOBAL RESEARCHINFORMATION TECHNOLOGY (IT)MARKET PLANNINGPHYSICAL FITNESSMARKETING & SALESHEALTH CAREMARKETING DIVISIONSINTERNATIONAL BUSINESS
Web Summary
Q1: What is the address of Deurali Janta Pharmaceuticals' corporate office?
A1: The corporate office of Deurali Janta Pharmaceuticals is based in Budhanilkantha Sadak, Bansabari-03, Kathmandu.
Q2: In what year was Deurali-Janta Pharmaceuticals established?
A2: Deurali-Janta Pharmaceuticals was established in 1988 by Mr. Hari Bhakta Sharma, the Executive Director of the company.
Q3: What is the name of the division established by DJPL in Sep. 2005 AD to promote chronic disease management?
A3: The new division established by DJPL in Sep. 2005 AD is named "SUSWASTHYA", which primarily focuses on promoting chronic disease management, especially in the segments of Cardiovascular, Endocrinology, and Nephrology.
Q4: What is the name of Deurali-Janta's specialized care division that brings its topical applications range for the very first time?
A4: The specialized care division of DJPL is named "AROGYAM", which was inaugurated on Aug. 25th, 2011, with an aim to serve with excellence.
Q5: What are some of the products and services offered by Deurali-Janta Pharmaceuticals?
A5: Deurali-Janta Pharmaceuticals offers a range of over-the-counter products and antibiotics for minor ailments, as well as specialized care divisions such as SUSWASTHYA, AROGYAM, NIROG, DIVYAM, and AARAMBHA, which cater to various health segments.
Q6: What is the focus of Deurali-Janta's primary care division, "NIROG", inaugurated on Jul. 26, 2013?
A6: The primary care division "NIROG" focuses on Neuropsychiatry and Pain Management.
Q7: How many international markets does Deurali-Janta Pharmaceuticals plan to export its products to soon?
A7: Deurali-Janta Pharmaceuticals plans to export its products to at least five international markets soon.
Q8: What is the first Nepalese pharmaceutical company to be awarded with a World Health Organization - Good Manufacturing Practice (WHO-GMP) certificate?
A8: Deurali-Janta Pharmaceuticals is the first Nepalese pharmaceutical company to be awarded with the WHO-GMP certificate.
A1: The corporate office of Deurali Janta Pharmaceuticals is based in Budhanilkantha Sadak, Bansabari-03, Kathmandu.
Q2: In what year was Deurali-Janta Pharmaceuticals established?
A2: Deurali-Janta Pharmaceuticals was established in 1988 by Mr. Hari Bhakta Sharma, the Executive Director of the company.
Q3: What is the name of the division established by DJPL in Sep. 2005 AD to promote chronic disease management?
A3: The new division established by DJPL in Sep. 2005 AD is named "SUSWASTHYA", which primarily focuses on promoting chronic disease management, especially in the segments of Cardiovascular, Endocrinology, and Nephrology.
Q4: What is the name of Deurali-Janta's specialized care division that brings its topical applications range for the very first time?
A4: The specialized care division of DJPL is named "AROGYAM", which was inaugurated on Aug. 25th, 2011, with an aim to serve with excellence.
Q5: What are some of the products and services offered by Deurali-Janta Pharmaceuticals?
A5: Deurali-Janta Pharmaceuticals offers a range of over-the-counter products and antibiotics for minor ailments, as well as specialized care divisions such as SUSWASTHYA, AROGYAM, NIROG, DIVYAM, and AARAMBHA, which cater to various health segments.
Q6: What is the focus of Deurali-Janta's primary care division, "NIROG", inaugurated on Jul. 26, 2013?
A6: The primary care division "NIROG" focuses on Neuropsychiatry and Pain Management.
Q7: How many international markets does Deurali-Janta Pharmaceuticals plan to export its products to soon?
A7: Deurali-Janta Pharmaceuticals plans to export its products to at least five international markets soon.
Q8: What is the first Nepalese pharmaceutical company to be awarded with a World Health Organization - Good Manufacturing Practice (WHO-GMP) certificate?
A8: Deurali-Janta Pharmaceuticals is the first Nepalese pharmaceutical company to be awarded with the WHO-GMP certificate.
Customs Data
As a purchaser
As a Supplier
Get the Whole details
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Get the Whole details
